Dendrimers as potential drug carriers. Part II. Prolonged delivery of ketoprofen by in vitro and in vivo studies

  • Man Na
  • , Cheng Yiyun
  • , Xu Tongwen
  • , Ding Yang
  • , Wang Xiaomin
  • , Li Zhenwei
  • , Chen Zhichao
  • , Huang Guanyi
  • , Shi Yunyu*
  • , Wen Longping
  • *Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

119 Scopus citations

Abstract

Ketoprofen, a non-steroidal anti-inflammatory drug with well-known anti-inflammatory, antipyretic and analgesic properties, has low solubility in water and causes local or systemic disturbance in the gastrointestinal tract. In the present study we investigated the potential of polyamidoamine (PAMAM) dendrimers as drug carriers of ketoprofen by in vitro and in vivo studies. The in vitro release of ketoprofen from the drug-dendrimer complex is significantly slower compared to pure ketoprofen. Anti-nociceptive studies using the acetic acid-induced writhing model in mice showed a prolonged pharmacodynamic behavior for the ketoprofen-PAMAM dendrimer complex. Also, the blood level studies were investigated. We concluded that PAMAM dendrimers might be considered as a potential drug carrier of ketoprofen with a sustained release behavior under suitable conditions.

Original languageEnglish
Pages (from-to)670-674
Number of pages5
JournalEuropean Journal of Medicinal Chemistry
Volume41
Issue number5
DOIs
StatePublished - May 2006
Externally publishedYes

Keywords

  • Drug carrier
  • Ketoprofen
  • PAMAM
  • Polyamidoamine dendrimers

Fingerprint

Dive into the research topics of 'Dendrimers as potential drug carriers. Part II. Prolonged delivery of ketoprofen by in vitro and in vivo studies'. Together they form a unique fingerprint.

Cite this